Vitrolife saw no growth in patent filings and highest growth of 0.99% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of Vitrolife’s patent filings and grants. Buy the databook here.
Vitrolife has been focused on protecting inventions in Canada(CA) with one publication in Q2 2024
The Canada(CA) Patent Office dominates the patent grants with nearly 50% of grants. The World Intellectual Property Organization(WIPO), Canada(CA), and United States(US) patent Office are among the top ten patent offices where Vitrolife is filings its patents. Among the top granted patent authorities, Vitrolife has 50% of its grants in Canada(CA) and 50% in United States(US).
Harvard University could be the strongest competitor for Vitrolife
In terms of grant share, Vitrolife stands first among its competitors followed by Harvard University and Vitrolife.
For comprehensive analysis of Vitrolife's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.